Skip to main content

ADVERTISEMENT

Videos

Shockwave at ISET
Sponsored Video
07/02/2024
Drs. Erik Stilp, Nicolas Mouawad, Liz Genovese and Kumar Madassery discuss their best practices when treating patients with below-the-knee disease.
Drs. Erik Stilp, Nicolas Mouawad, Liz Genovese and Kumar Madassery discuss their best practices when treating patients with below-the-knee disease.
Drs. Erik Stilp, Nicolas...
07/02/2024
Vascular Disease Management
Dr Rakesh Jain
Videos
07/02/2024
Learn about the safety and efficacy of these new agents and gain insights into improving diagnosis and treatment strategies. 
Learn about the safety and efficacy of these new agents and gain insights into improving diagnosis and treatment strategies. 
Learn about the safety and...
07/02/2024
Psych Congress Network
Peter Galle, MD, PhD
Conference Coverage
07/02/2024
Peter Galle, MD, PhD, discussed results from the CheckMate 9DW trial which identified nivolumab plus ipilimumab as a potential new first-line option for patients with previously untreated, unresectable hepatocellular carcinoma.
Peter Galle, MD, PhD, discussed results from the CheckMate 9DW trial which identified nivolumab plus ipilimumab as a potential new first-line option for patients with previously untreated, unresectable hepatocellular carcinoma.
Peter Galle, MD, PhD, discussed...
07/02/2024
Oncology
David Rubin
Conference Coverage
07/02/2024
Dr Rubin recaps his address at Digestive Disease Week on positioning advanced therapies in IBD, emphasizing the importance of assessing disease activity, prognosis for complications, and using a treat to target approach to achieve and...
Dr Rubin recaps his address at Digestive Disease Week on positioning advanced therapies in IBD, emphasizing the importance of assessing disease activity, prognosis for complications, and using a treat to target approach to achieve and...
Dr Rubin recaps his address at...
07/02/2024
Advances in Inflammatory Bowel Disease Network
Andrea Cercek, MD
Conference Coverage
07/01/2024
Andrea Cercek, MD, discussed results from a phase 2 study which demonstrated durable recurrence-free with neoadjuvant dostarlimab among patients with locally advanced mismatch repair deficient rectal cancer.
Andrea Cercek, MD, discussed results from a phase 2 study which demonstrated durable recurrence-free with neoadjuvant dostarlimab among patients with locally advanced mismatch repair deficient rectal cancer.
Andrea Cercek, MD, discussed...
07/01/2024
Oncology
andrew penn
Videos
07/01/2024
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP, discusses the recent vote by the FDA's advisory committee (PDAC) against an MDMA-based therapy for the treatment of PTSD in adults and sheds light on what this means for the future of PTSD treatment.
Andrew Penn, MS, PMHNP,...
07/01/2024
Psych Congress Network
BDHC thumbnail
Breaking Down Health Care
07/01/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, examine how to measure quality in health care and the current challenges with the existing methods.
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, examine how to measure quality in health care and the current challenges with the existing methods.
In this Breaking Down Health...
07/01/2024
Cancer Care Business Exchange
Video
07/01/2024
Dr. Jordan discusses the 5-year results.
Dr. Jordan discusses the 5-year results.
Dr. Jordan discusses the 5-year...
07/01/2024
Vascular Disease Management
Illustration of two women talking
SPONSORED VIDEO
06/28/2024
Listen to Megan, an adult with ADHD, and her best friend talk about her ADHD journey, including current treatment with a nonstimulant medication.
Listen to Megan, an adult with ADHD, and her best friend talk about her ADHD journey, including current treatment with a nonstimulant medication.
Listen to Megan, an adult with...
06/28/2024
Psych Congress Network
Efrat Dotan, MD
Conference Coverage
06/28/2024
Efrat Dotan, MD, discussed results from the phase 2 GIANT study which compared gemcitabine and nab-paclitaxel to 5-fluorouracil, leucovorin, and liposomal irinotecan among older adults with treatment-naive metastatic pancreatic cancer.
Efrat Dotan, MD, discussed results from the phase 2 GIANT study which compared gemcitabine and nab-paclitaxel to 5-fluorouracil, leucovorin, and liposomal irinotecan among older adults with treatment-naive metastatic pancreatic cancer.
Efrat Dotan, MD, discussed...
06/28/2024
Oncology